Su Lu, Gao Peiyi
Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Neuroradiology Center of Beijing, Neurosurgical Institute, Beijing, China.
Front Neurol. 2023 Jul 25;14:1154823. doi: 10.3389/fneur.2023.1154823. eCollection 2023.
This study aimed to investigate the diagnostic performance of volume mismatch sign on discriminating paramedial bithalamic tumors from non-tumors.
In this study, we recruited patients with tumors or non-tumors of the paramedial bithalamus. We confirmed the diagnosis by pathology, laboratory tests documented in medical records, medical imaging at the baseline, or through at least 1 year of follow-up. Cases with paramedial thalamic lesions on only one side or purely midbrain illnesses were excluded. Additionally, any case without involvement of the medial thalami (i.e., those with one or both-sided anterior, lateral, or posterior thalamic lesions) was excluded. Two neuroradiologists were trained independently to evaluate volume mismatch sign on magnetic resonance T2-weighted images or T2 fluid-attenuated inversion recovery images. A positive volume mismatch sign means that the ratio of the larger-sided lesion volume to the smaller-sided lesion volume is >150%. The volume of each lesion was calculated by multiplying the anteroposterior diameter by the left-right diameter and by the height of the lesion and then dividing by 2. The kappa value was calculated to show the consistency between the two observers. The chi-square test was used to evaluate differences in volume mismatch sign between the bilthalamic midline tumor and non-tumor groups. The positive (PPV) and negative (NPV) predictive values, sensitivity, and specificity were calculated to evaluate the ability of volume mismatch sign to differentiate paramedial bilateral thalamus tumors from non-tumors. A two-tailed ≤ 0.05 was considered to be statistically significant. The analyses were performed using the statistical software SPSS version 26.
A total of 96 patients were enrolled in this study between March 2012 and October 2022. A high agreement between the two observers on the volume mismatch sign of bilateral paramedian thalamic diseases was found, and the Kappa value was 0.828. A statistically significant difference was observed for the volume mismatch sign between the paramedial bithalamic tumor and the non-tumorous groups (χ = 35.465, < 0.001). The presence of volume mismatch sign in paramedial bithalamic illnesses predicted the presence of tumors with a sensitivity and specificity of 69.2% and 90.9%, respectively, and PPV and NPV were 90.0% and 71.4%.
Volume mismatch sign may indicate tumors in paramedian bithalamic diseases.
本研究旨在探讨体积不匹配征在鉴别双侧丘脑旁肿瘤与非肿瘤性病变中的诊断效能。
本研究纳入了双侧丘脑旁患有肿瘤或非肿瘤性病变的患者。我们通过病理检查、病历中记录的实验室检查、基线时的医学影像或至少1年的随访来确诊。仅一侧丘脑旁有病变或单纯中脑疾病的病例被排除。此外,任何未累及内侧丘脑的病例(即单侧或双侧丘脑前部、外侧或后部有病变的病例)也被排除。两名神经放射科医生独立接受培训,以评估磁共振T2加权图像或T2液体衰减反转恢复图像上的体积不匹配征。体积不匹配征阳性是指较大侧病变体积与较小侧病变体积之比>150%。每个病变的体积通过将前后径乘以左右径再乘以病变高度,然后除以2来计算。计算kappa值以显示两位观察者之间的一致性。采用卡方检验评估双侧丘脑中线肿瘤组与非肿瘤组在体积不匹配征方面的差异。计算阳性预测值(PPV)、阴性预测值(NPV)、敏感性和特异性,以评估体积不匹配征区分双侧丘脑旁肿瘤与非肿瘤的能力。双侧检验P≤0.05被认为具有统计学意义。分析使用统计软件SPSS 26版进行。
2012年3月至2022年10月期间,本研究共纳入96例患者。发现两位观察者对双侧丘脑旁疾病的体积不匹配征有高度一致性,kappa值为0.828。双侧丘脑旁肿瘤组与非肿瘤组在体积不匹配征方面存在统计学显著差异(χ² = 35.465,P < 0.001)。双侧丘脑旁疾病中体积不匹配征的存在预测肿瘤的存在,敏感性和特异性分别为69.2%和90.9%,PPV和NPV分别为90.0%和71.4%。
体积不匹配征可能提示双侧丘脑旁疾病中的肿瘤。